BioLineRx reports results of extraordinary meeting of shareholders
false
ביוליין אר אקס בע"מ
2
380
BIOLINE RX LTD
Corporation no:
513398750
9253
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
05/03/2020
www.isa.gov.il
www.tase.co.il
Reference:
2020-02-018865
Time of broadcast:
16:51
16:48:15
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
BioLineRx reports results of extraordinary meeting of shareholders
6-K_EGM_Mar2020_results_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2020-02-009856
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
18/02/2020
Address:
HaMa'ayan
2
,
Modi'in
7177871
,
Israel
Tel:
08-6429100
,
Fax:
08-6429101
E-mail address:
info@BioLineRx.com
Company site:
www.biolinerx.com
Previous names of reporting entity:
Name of the Signatory:
Kotler Norman Harold
Position of Signatory in the reporting corporation:
General Counsel & Company Secretary
Name of Employer Company:
Address:
HaMa'ayan
2
,
Modi'in
7177871
Telephone:
08-6429100
Facsimile:
08-6429101
E-mail:
normank@biolinerx.com
1
Israel